206 related articles for article (PubMed ID: 31982142)
1. Therapeutic Germline Editing: Sense and Sensibility.
Adashi EY; Cohen IG
Trends Genet; 2020 May; 36(5):315-317. PubMed ID: 31982142
[TBL] [Abstract][Full Text] [Related]
2. The promise and challenge of therapeutic genome editing.
Doudna JA
Nature; 2020 Feb; 578(7794):229-236. PubMed ID: 32051598
[TBL] [Abstract][Full Text] [Related]
3. Ethics of Human Genome Editing.
Coller BS
Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366
[TBL] [Abstract][Full Text] [Related]
4. National Academies relax stance on germline edits.
Sheridan C
Nat Biotechnol; 2017 Apr; 35(4):295-296. PubMed ID: 28398320
[No Abstract] [Full Text] [Related]
5. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
6. CRISPR gene editing in human embryos wreaks chromosomal mayhem.
Ledford H
Nature; 2020 Jul; 583(7814):17-18. PubMed ID: 32606465
[No Abstract] [Full Text] [Related]
7. First in vivo human genome editing trial.
Nat Biotechnol; 2018 Jan; 36(1):5. PubMed ID: 29319687
[No Abstract] [Full Text] [Related]
8. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
Burbery R
J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
Jacinto FV; Link W; Ferreira BI
J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
[TBL] [Abstract][Full Text] [Related]
10. Heritable Human Genome Editing: The Public Engagement Imperative.
Adashi EY; Burgess MM; Burall S; Cohen IG; Fleck LM; Harris J; Holm S; Lafont C; Moreno JD; Neblo MA; Niemeyer SJ; Rowe EJ; Scheufele DA; Tetsa PF; Vayena E; Watermeyer RP; Fung A
CRISPR J; 2020 Dec; 3(6):434-439. PubMed ID: 33346718
[TBL] [Abstract][Full Text] [Related]
11. Ordo-Responsibility for Germline Gene Editing.
Ranisch R; Rudolph T; Cremer HJ; Knoepffler N
CRISPR J; 2020 Feb; 3(1):37-43. PubMed ID: 32091257
[TBL] [Abstract][Full Text] [Related]
12. What Do We Really Think About Human Germline Genome Editing, and What Does It Mean for Medicine?
Musunuru K; Lagor WR; Miano JM
Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 28974517
[TBL] [Abstract][Full Text] [Related]
13. Target Discovery for Precision Medicine Using High-Throughput Genome Engineering.
Guo X; Chitale P; Sanjana NE
Adv Exp Med Biol; 2017; 1016():123-145. PubMed ID: 29130157
[TBL] [Abstract][Full Text] [Related]
14. Making sense of heritable human genome editing: Scientific and ethical considerations.
Greenfield A
Prog Mol Biol Transl Sci; 2021; 182():1-28. PubMed ID: 34175039
[TBL] [Abstract][Full Text] [Related]
15. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Therapeutic Genome Editing in China.
Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
[TBL] [Abstract][Full Text] [Related]
17. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
18. The ethics of creating genetically modified children using genome editing.
Ishii T
Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):418-423. PubMed ID: 28885275
[TBL] [Abstract][Full Text] [Related]
19. [A new milestone in human embryo editing].
Jordan B
Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733
[TBL] [Abstract][Full Text] [Related]
20. Procreative Non-Maleficence: A South African Human Rights Perspective on Heritable Human Genome Editing.
Thaldar D; Shozi B
CRISPR J; 2020 Feb; 3(1):32-36. PubMed ID: 32091250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
